Development of methodological approaches to the effective implementation of the socially oriented policy in the pharmaceutical market of Ukraine
DOI:
https://doi.org/10.24959/sphhcj.25.346Keywords:
public health policy; socially oriented policy; socially oriented commodity policy; pharmaceutical care; pharmaceutical marketAbstract
Aim. To develop methodological approaches to the effective implementation of the socially oriented policy in the pharmaceutical market of Ukraine
Materials and methods. Historical, analytical-comparative, systemic, graphic, logical, hypothetical-deductive and other methods of theoretical research were used. The study subject was the system of pharmaceutical provision for the population in Ukraine under the conditions of strengthening the humanistic principles of the social development.
Results. Based on the results of theoretical research, methodological approaches for the effective implementation of a socially oriented policy in the pharmaceutical market have been developed. The goal has been defined, the tasks have been outlined, and the nature of the functioning of the specified policy in the pharmaceutical market has been described. The main functions (social, stabilizing, stimulating, integrating, controlling, organizational-coordinating, information-correcting) of the implementation of the specified policy have been presented and described. The principles of its implementation in the pharmaceutical market have been outlined with an assessment of the priority of their implementation, which makes it possible to divide them into two groups. The levels (international, national, regional, microeconomic), subjects and objects, terms, conditions and objective obstacles to the effective implementation of the socially oriented policy in the pharmaceutical market of Ukraine have been determined. The directions for implementing the specified policy have been presented in accordance with the levels of pharmaceutical care provided to the population (life-supporting, health-saving, and service level). Based on the results of the systematization and generalization of the research conducted, a strategic dossier has been developed for the process of implementing the socially oriented policy in the pharmaceutical market of Ukraine in accordance with the goals of the National Drug Policy.
Conclusions. The implementation of this policy in various directions, levels and terms of its implementation will form an objective basis for transforming the content of relations between the state, society and drug manufacturers on the way to achieving socially fair access of the population to effective medicines in the conditions of the existing resource support of the healthcare system.
References
Declaration of Alma-Ata International Conference on Primary Health Care. Alma-Ata. 06-12 September, 1978. http://www.who.int/publications/almaata_declaration_en.pdf
Sekhar, K. S., Sekhar, P. H., & Prasad, M. G. (2010). Concept of Essential Medicines and Rational Use in Public Health. Indian Journal Community Medicine, 35(1), 10–13.
Zarocostas, J. (2007). Better access to medicines could save 10 million lives a year, says UN expert. BMJ, 335(7621), 635. https://pubmed.ncbi.nlm.nih.gov/17901494/
Mahmić-Kaknjo, M., Jeličić-Kadić, A., Utrobičić, A., Chan, K., Bero, L., & Marušić, A. (2018). Essential medicines availability is still suboptimal in many countries: a scoping review. Journal of Сlinical Еpidemiology, 98, 41–52.
Fulone, I., Cadogan, C., Barberato-Filho, S., Bergamaschi, C. C., Mazzei, L. G., Lopes, L. P., Silva, M. T., & Lopeset, L. C. (2023). Pharmaceutical policies: effects of policies regulating drug marketing. Cochrane Database Syst Rev., (6), CD013780. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250001/
Haque, M. (2017). Essential Medicine Utilization and Situation in Selected Ten Developing Countries: A Compendious Audit. J. In.t Soc. Pre.v Community Dent., 7(4). 147–160.
Backman, G., Hunt, P., Khosla, R., Jaramillo-Strouss, C., Fikre, B. M., Rumble, C., Pevalin, D., Páez, D. A., Pineda, M. A., Frisancho, A., Tarco, D., Motlagh, M., Farcasanu, D., & Vladescu, C. (2008). Health systems and the right to health: an assessment of 194 countries. Lancet, 372(9655), 2047–2085.
WHA Resolution The Sixty-ninth World Health Assembly. https://apps.who.int/gb/ebwha/pdf_files/WHA69-REC1/A69_2016_REC1-en.pdf
Addressing the global shortage of, and access to, medicines and vaccines Report by the Director-General. https://apps.who.int/gb/ebwha/pdf_files/EB142/B142_13-en.pdf
Sustainable Development Goals. Goal 3. Good health and well-being. https://www.undp.org/sustainable-development-goals/good-health
The 2024 Access to Medicine Index. Access to medicine foundation. https://accesstomedicinefoundation.org/news/pharma-companies-still-not-maximising-their-potential-to-reach-more-patients-in-low-and-middle-income-countries
Suzanne, R. H. (2015). Affordable innovation: future directions in pharmaceutical policy. Journal of Pharmaceutical Policy and Practice, 8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602179/
Gautier, L., & Pierre-Marie, D. (2015). Health for all and the challenges for pharmaceutical policies: A critical interpretive synthesis over 40 years. J. Pharm. Policy Pract, 8(1). https://joppp.biomedcentral.com/articles/10.1186/2052-3211-8-S1-K1
Guidebook on How to Develop a Public–Private Partnership in Pharmacy. Asian Development Bank. 2013. https://www.adb.org/sites/default/files/project-documents//41664-012-phi-tacr-01-a7.2.pdf
Andrew, M. D., Engkvist, O., Fairclough, R. J., Feierberg, I., Freeman, A., & Iyer, P. (2021). Public-Private Partnerships: Compound and Data Sharing in Drug Discovery and Development. SLAS Discovery, 26(5), 604–619. https://www.sciencedirect.com/science/article/pii/S2472555222067090
Laverty, H., & Meulien, P. (2019). The Innovative Medicines Initiative – 10 Years of Public-Private Collaboration. Front. Med., (6), 275.
Holden, D. J., Reiter, K., O’Brien, D., & Dalton, K. (2015). The Strategic Case for Establishing Public Private Partnerships in Cancer Care. Health Res. Policy Syst., (3), 1–9.
Access to Medicine Index 2022. Access to medicine foundation. https://accesstomedicinefoundation.org/medialibrary/2022_access-to-medicine-index-1669982470.pdf
Fatoye, C., Yeowell, G., Miller, E., Odeyemi, I., & Mbada, C. (2024). Conceptualisation and Role of Market Access in Pharmaceutical Industry: A Scoping Review. J. Mark. Access Health Policy, 12(2), 81–99. https://www.mdpi.com/2001-6689/12/2/7
Policy Options for Promoting the Use of Generic Medicines in Lowand Middle-income Countries. March 2016. http://haiweb.org/wp-content/uploads/2017/02/HAI_Review_generics_policies_final.pdf
Williams, S. J., Martin, P., & Gabe, J. (2011). The pharmaceuticalisation of society? A framework for analysis. Sociol. Health Illn, 33(5), 710–725. https://pubmed.ncbi.nlm.nih.gov/21371048/
Petrak, K. (2017). On Accelerating Medicines Partnership Initiative: Better Diagnosis without Better Therapies? Failure of Clinical Trials Mod. Appl. Bioequiv. Bioavail, (2), 555–580.
Public-private Partnerships in Biomedical Research and Health Innovation for Alzheimer’s Disease and other Dementias. 2015. https://www.oecd.org/content/dam/oecd/en/publications/reports/2015/04/public-private-partnerships-in-biomedical-research-and-health-innovation-for-alzheimer-s-disease-and-other-dementias_g17a2627/5js36rc8wwbt-en.pdf
Рublic-private partnerships for Health care infrastructure and services: considerations for policy makers in Ukraine. https://iris.who.int/bitstream/handle/10665/359561/WHO-EURO-2022-5713-45478-65097-eng.pdf?sequence=1
Tkachenko, N. O., & Chervonenko, N. M. (2012). Aktualnist sotsialnoi vidpovidalnosti u farmatsii. Aktualni pytannia farmatsevtychnoi i medychnoi nauky ta praktyky, 1(8), 106–108.
Bratishko, Yu. S. (2015). Rozrobka alhorytmu formuvannia systemy sotsialnoi vidpovidalnosti farmatsevtychnykh pidpryiemstv. Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii, (4), 52–59.
Kotvitska, A. A., & Kostiuk, V. H. (2016). Doslidzhennia suchasnykh pidkhodiv do formuvannia asortymentnoi polityky vitchyznianykh farmatsevtychnykh pidpryiemstv. Sotsialna farmatsiia v okhoroni zdorovia, 2(2), 37–43.
Mnushko, Z. M., & Dikhtiarova, N. M. (2010). Menedzhment ta marketynh u farmatsii. Ch. 2. Marketynh u farmatsii: pidruch. dlia studentiv VNZ (2-he vyd., dopov. ta pererob.). NFaU: Zoloti storinky.
Dikhtiarova, N. M. Tovarna polityka. Farmatsevtychna entsyklopediia. https://www.pharmencyclopedia.com.ua/article/2229/tovarna-politika
Lisovskyi, P. M., & Lisovska, Yu. P. (2012). Politolohiia: navch. posib. Kondor.
Modebadze, V. (2010). The Term Politics Reconsidered in the Light of Recent Theoretical Developments. IBSU Scientific Journal, 1(4), 39–44. https://www.econstor.eu/bitstream/10419/54647/1/644242132.pdf
Worth, O. (2015). Rethinking Hegemony. Palgrave Macmillan.
Mansbach, R., & Taylor, K. (2017). Introduction to Global Politics. Routledge.
Nemchenko, A. S., Panfilova, H. L., & Propisnova, V. V. (2009). Dialektyka ta metodolohiia orhanizatsii farmatsevtychnoi dopomohy naselenniu za umov vprovadzhennia oboviazkovoho medychnoho strakhuvannia. Klinichna farmatsiia, (1), 31–36.
Panfilova, H. L. (2014). Farmatsevtychna dopomoha yak istorychna, sotsialno-ekonomichna ta normatyvno–pravova katehoriia v systemi okhorony zdorovia y farmatsevtychnomu zabezpechenni naselennia. Aktualni pytannia farmatsevtychnoi i medychnoi nauky ta praktyky, (2), 89–97.
Hala, L., & Panfilova, H. (2019). Analysis of the creation of a modern pharmaceutical support system in Ukraine in a retrospective development of the state and civil society relations. EUREKA: Health Sciences, (5), 34–43.
Stratehiia rozvytku systemy okhorony zdorovia do 2030 roku. Finalizovanyi ta pohodzhenyi chlenamy Mizhsektoralnoi robochoi hrupy z pytan rozrobky Stratehii rozvytku systemy okhorony zdorovia do 2030 roku. https://moz.gov.ua/uploads/ckeditor/%D0%A1%D1%82%D1%80%D0%B0%D1%82%D0%B5%D0%B3%D1%96%D1%8F/UKR%20Health%20Strategy%20Feb%2024.2022.pdf
Evaluation of the “Affordable medicines programme” in Ukraine. (2019). WHO. https://iris.who.int/bitstream/handle/10665/311229/9789289054003-eng.pdf?sequence=1
Ukaz Prezydenta Ukrainy “Pro dodatkovi zakhody shchodo zabezpechennia dostupnosti likarskykh zasobiv dlia ukraintsiv” No. 82/2025 (2025, Liutyi 12). https://www.president.gov.ua/documents/822025-53781
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
